Australia markets closed

Armata Pharmaceuticals, Inc. (ARMP)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.49000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-32,650
-69,045
-36,917
-23,155
-22,181
Depreciation & amortisation
924
972
892
1,169
1,114
Stock-based compensation
2,952
938
3,105
2,882
3,475
Change in working capital
-1,820
-9,646
439
-3,223
-874
Accounts payable
39
39
3,665
184
544
Other working capital
-33,488
-55,567
-34,692
-24,879
-19,094
Other non-cash items
25,414
25,414
-
60
628
Net cash provided by operating activities
-30,594
-47,423
-32,481
-23,575
-18,270
Cash flows from investing activities
Investments in property, plant and equipment
-2,894
-8,144
-2,211
-1,304
-824
Net cash used for investing activities
-2,894
-8,134
-2,211
-1,304
-824
Cash flows from financing activities
Common stock issued
51,347
0
44,391
26,319
22,893
Other financing activities
-43
-43
-500
-1,414
-568
Net cash used provided by (used for) financing activities
51,554
53,988
44,016
25,518
23,210
Net change in cash
18,066
-1,569
9,324
639
4,116
Cash at beginning of period
13,276
20,812
11,488
10,849
6,733
Cash at end of period
31,342
19,243
20,812
11,488
10,849
Free cash flow
Operating cash flow
-30,594
-47,423
-32,481
-23,575
-18,270
Capital expenditure
-2,894
-8,144
-2,211
-1,304
-824
Free cash flow
-33,488
-55,567
-34,692
-24,879
-19,094